Ravi Bandaru

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study

This study identifies a novel cfDNA fragmentomic metric, rMDS, that distinguishes immunotherapy responders from non-responders in HNSCC with high accuracy.

Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study

This study identifies circulating cell-free DNA methylation profiles as potential non-invasive biomarkers for multiple sclerosis, showing their ability to classify subtypes, estimate severity, and predict progression.

FinaleToolkit: Accelerating Cell-Free DNA Fragmentation Analysis with a High-Speed Computational Toolkit

FinaleToolkit accelerates cfDNA fragmentation analysis by generating comprehensive features efficiently, improving processing speed by up to 50-fold for large datasets.

FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA

FinaleMe predicts DNA methylation and tissues-of-origin from plasma whole-genome sequencing by using a non-homogeneous Hidden Markov Model.